March 31, 2014

How Close Are We to an Approved Treatment? - Bernard Munos

Thumbnail

How Close Are We to an Approved Treatment? - Bernard Munos

About This Episode

A discussion with Bernard Munos, Founder of InnoThink, and named one of the 25 most influential people in biopharma by FiercePharma.  He discussed his analysis of the drug pipeline, the status of drugs in it, as well as his recommendations for how we can organize research more effectively and lower the cost of innovation and reduce the risk of failure so that we can get to a cure faster and at lower cost.

This call was made possible by the generous support of the Zickler Family Foundation.

BrainStorm Feed

119

The Fine Print on Your Prescriptions: What Families Need to Know About Medicare Part D

You picked a Medicare drug plan in December. Then in January, the pharmacist tells you your medication isn’t covered, or that it needs approval first

LISTEN NOW
118

Risky Business: The Costliest Assumptions for Medicare Families

In part one of BrainStorm’s look at Medicare open enrollment, host Meryl Comer talks with Alison Schneider, Director of Market Access Policy and Strategy at

LISTEN NOW
117

Beyond Amyloid: Why Protecting Synapses Could Change Alzheimer's Prevention with Dr. Frank Longo

Blood tests and brain scans can now show signs of Alzheimer's up to 20 years before symptoms appear. So what can we do with that

LISTEN NOW